Status:
ENROLLING_BY_INVITATION
A Long Term Follow-Up Study for Subjects Who Have Received Q-Cells
Lead Sponsor:
University of Texas Southwestern Medical Center
Conditions:
Transverse Myelitis
Eligibility:
All Genders
Brief Summary
This study is an observational study designed to obtain information on the long-term safety, tolerability, and continued activity of Q-Cells®. The study will follow the participants who previously rec...
Eligibility Criteria
Inclusion
- Subjects must have been administered Q-Cells® as part of Protocol QTM-101 or other treatment Protocol.
- Subjects must have the ability to understand the purpose and risks of the study and provide signed and dated informed consent and authorization to collect and use protected health information (PHI) in accordance with national and local subject privacy regulations.
Exclusion
- 1\. The study is intended to follow all subjects who have received Q-Cells® without exception.
Key Trial Info
Start Date :
December 12 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2035
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT06163508
Start Date
December 12 2023
End Date
December 1 2035
Last Update
April 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The University of Texas Southwestern Medical Center
Dallas, Texas, United States, 75390